View Single Post
  #2  
Old Fri Oct 10, 2008, 06:37 AM
Birgitta-A Birgitta-A is offline
Member
 
Join Date: Oct 2007
Location: Stockholm, Sweden
Posts: 1,918
Sapacitabine - enrollment Phase II for AML patients completed

Hi all,
Now they have 60 AML patients - at least 70 yo - in the Phase II study of Sapacitibine. They continue to enroll patients MDS patients who have been previously treated with hypomethylating agents.
http://production.investis.com/cyc/i...08/2008-10-09/
Kind regards
Birgitta-A
Reply With Quote